Document Detail


The use of bisphosphonates in women prior to or during pregnancy and lactation.
MedLine Citation:
PMID:  22281884     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: The unique pharmacokinetics of bisphosphonates (BPs) in conjunction with their use by an increasing number of women at reproductive age has raised serious concerns about their safety during pregnancy and lactation. Bisphosphonates cross the placenta. Animal studies have shown adverse effects on both the fetus and the mother, mostly at doses much higher than those commonly used in humans. Protracted parturition, maternal mortality, embryolethality, severe general underdevelopment and marked skeletal retardation of the fetuses (increased amount of diaphyseal bone trabeculae, decreased diaphyseal length), small fetal weight and abnormal tooth growth have been observed.
DESIGN: We conducted a thorough research of the literature in order to identify human studies concerning this issue.
RESULTS: We identified a total of 78 cases involving fetuses whose mothers had been exposed to BPs before conception or during pregnancy, along with 7 cases of BPs exposure prior to or during lactation. The vast majority of mothers and infants did not demonstrate serious adverse effects. However, there were cases of shortened gestational age, low neonatal birth weight and transient hypocalcaemia of the newborns, while the very few reported cases of spontaneous abortions and congenital anomalies probably resulted from maternal underlying diseases and concomitant medication.
CONCLUSION: The administration of bisphosphonates in pregnancy should be assessed in view of their potential hazardous effects on both mother and fetus. In cases of absolute or relative indications of BPs prior to pregnancy, close observation of the mother and the infant, especially during the first two weeks of life, is imperative for the successful outcome of pregnancy.
Authors:
Ioannis P Stathopoulos; Chrysoula G Liakou; Aikaterini Katsalira; George Trovas; George G Lyritis; Nikolaos A Papaioannou; Symeon Tournis
Related Documents :
12039464 - The immunophenotype of patients with recurrent pregnancy loss.
12594944 - At the innate frontiers between mother and fetus: linking abortion with complement acti...
20977424 - Pro-inflammatory cytokines in animal and human gestation.
14267744 - Active immunization of women in pregnancy for prevention of neonatal tetanus.
17367914 - South asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadot...
8447354 - Contraceptive efficacy of a monophasic oral contraceptive containing desogestrel.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hormones (Athens, Greece)     Volume:  10     ISSN:  1109-3099     ISO Abbreviation:  Hormones (Athens)     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2012-01-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101142469     Medline TA:  Hormones (Athens)     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  280-91     Citation Subset:  IM    
Affiliation:
Laboratory for the Research of Musculoskeletal System "Th. Garofalidis", KAT Hospital, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis and management of hyperglycemic emergencies.
Next Document:  Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystan...